Fariba Ghaidi - Concepedia

Author

Fariba Ghaidi

University of British Columbia ORCID

Also Known As

Fariba Ghaidi

Publications

432

Citations

H-Index

Concepts

All Affiliations

University of British Columbia Canada's Michael Smith Genome Sciences Centre Vancouver General Hospital BC Cancer Agency St. Paul's Hospital

About

Fariba Ghaidi is an author at University of British Columbia specializing in medicine, tumor biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	176
2	Natural Sciences	1	1	45
3	Cell Biology	1	1	45
4	Molecular Biology	1	1	45
5	Pathology	1	1	53

Fariba Ghaidi

Publications

413

Citations

H-Index

Page 1

	Year	Citations
Short Hairpin RNA Knockdown of the Androgen Receptor Attenuates Ligand-Independent Activation and Delays Tumor Progression Helen Cheng, Rob Snoek, Fariba Ghaidi, Cancer Research	2006	126
Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer Lavinia A. Carabet, Nada Lallous, Eric Leblanc, European Journal of Medicinal Chemistry Medicinal ChemistryUrologyComputer-aided Drug DiscoveryDrug TargetMedicine	2018	58
Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer Lavinia A. Carabet, Eric Leblanc, Nada Lallous, Molecules	2019	54
Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis Sam M. Wiseman, Adrienne Melck, Hamid Masoudi, Annals of Surgical Oncology Thyroid TumorsMarker PanelMedicineThyroid DiseasePathology	2008	53
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer Miriam Butler, Mani Roshan‐Moniri, Michael Hsing, Oncotarget Dna BindingNatural SciencesErg Protein VariantsSmall MoleculesReceptor Tyrosine Kinase	2017	45
A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma Louise Ramos, Sarah Truong, Beibei Zhai, Clinical Cancer Research	2023	22
Raft-Dependent Endocytosis of Autocrine Motility Factor/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor Cells Liliana D. Kojic, Sam M. Wiseman, Fariba Ghaidi, PLoS ONE	2008	21
Carbidopa abrogates <scp>L</scp>‐dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression Latif A. Wafa, Helen Cheng, Nathan Plaa, International Journal of Cancer Molecular PharmacologyAndrogen ReceptorUrologyProstate Tumor GrowthMedicine	2011	20
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer Eric Leblanc, Fuqiang Ban, Ayşe Derya Cavga, Journal of Medicinal Chemistry	2021	14

Page 1